Overview
SNSE market data
Price History
SNSE price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$16.72 Diluted earnings per share over the trailing twelve months.
- Beta
- -0.33 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $6.33 – $37.90 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $19.5 · P/B 0.72.
Company News
8-K filing — Faeth Therapeutics, Inc. (SNSE)SEC EDGAR · Jun 18, 2026, 9:13 PM
BTIG Reiterates Buy on Sensei Biotherapeutics, Maintains $55 Price TargetBenzinga · Jun 15, 2026, 5:10 PM
Sensei Biotherapeutics Changes Corporate Name To Faeth Therapeutics, Ticker To FTH, Effective June 16; Appoints Anand Parikh Chairman, President And CEO; Brian Stephenson Appointed CFO, Effective June 12Benzinga · Jun 15, 2026, 12:20 PM
8-K filing — Sensei Biotherapeutics, Inc. (SNSE)SEC EDGAR · Jun 15, 2026, 12:16 PM
Sensei Biotherapeutics shares are trading higher after BTIG initiated coverage on the stock with a Buy rating and announced a $55 price target.Benzinga · Jun 11, 2026, 5:09 PM
This MarketAxess Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For ThursdayBenzinga · Jun 11, 2026, 3:42 PM
This Henry Schein Analyst Turns Bullish; Here Are Top 5 Upgrades For ThursdayBenzinga · Jun 11, 2026, 12:05 PM
This Daktronics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For ThursdayBenzinga · Jun 11, 2026, 11:17 AM
BTIG Initiates Coverage On Sensei Biotherapeutics with Buy Rating, Announces Price Target of $55Benzinga · Jun 11, 2026, 10:15 AM
Cantor Fitzgerald Initiates Coverage On Sensei Biotherapeutics with Overweight RatingBenzinga · May 29, 2026, 2:45 PM